News

Deal Announcements

Meditope Bio Lands Series A Venture Capital

Monday, July 29, 2013 5:36:00 AM PDT | VentureDeal
Pasadena, California  --  Biotechnology company Meditope Biosciences has received $3.6 million in its first round of venture capital financing.

Meditope is developing monoclonal antibody technology that will enable drugs to attach and detach to antibodies without the need for chemical conjugation.

Investors in the financing were not disclosed.

The company said it would use the financing to accelerate development of its antibody-based cancer products.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1